Details for Patent: 6,225,284

Summary for Patent: 6,225,284

Title:	Somatostatin peptides
Abstract:	Somatostain analogues comprising the amino acid sequence of the formula (I): -(D/L)Trp-Lys-X.sub.1 -X.sub.2, wherein X.sub.1 is a substituted Thr, Ser, Tyr, Glu or Cys residue and X.sub.2 is an .alpha.-amino acid having an aromatic residue on the C.sub..alpha. side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His (Bzl)HyPro, thienyl-Ala, cyclohexyl-Ala and t.-butyl-Ala, the residue Lys of said sequence corresponding to the residue Lys.sup.9 of the native somatostatin-14, in free form, in salt form or complexed with a detectable element have interesting pharmacological properties.
Inventor(s):	Albert; Rainer (Basel, CH), Bauer; Wilfried (Lampenberg, CH), Bruns; Christian (Freiburg, DE), Chandramouli; Nagarajan (Morristown, NJ), Lewis; Ian (Riehen, CH), Weckbecker; Gisbert (Biel-Benken, CH)
Assignee:	Novartis AG (Basle, CH)
Application Number:	08/981,426
Patent Claim Types: see list of patent claims	Compound; Process; Composition; Use;

Drugs Protected by US Patent 6,225,284

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,225,284

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9513224	Jun 29, 1995
United Kingdom	9600429	Jan 10, 1996

PCT Information
PCT Filed	June 28, 1996	PCT Application Number:	PCT/EP96/02840
PCT Publication Date:	January 16, 1997	PCT Publication Number:	WO97/01579

International Family Members for US Patent 6,225,284

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	004497
Austria	210152
Australia	6515096
Australia	714447